Published on

750,000 women in the US could be injured by a birth control device that is no longer being sold.

Essure is a permanent birth control procedure involves implanting a soft, flexible insert is placed into each of fallopian tube. Essure was approved by the FDA in 2002.  However, the device was associated with a number of risks, including:

  • Puncture or tear of the uterus or colon
  • Chronic pelvic pain
  • Discharge  of the Essure
  • Life-threatening ectopic pregnancy
  • Movement of the Essure device itself or any component of the Essure
  • Additional surgeries (including hysterectomy)
  • Fetal death

Other problems include severe migraines and/or allergic reactions and autoimmune responses such as fatigue, rashes, hair loss and weight gain.

Bayer finally warned of these problems and withdrew the product from other markets. It has only announced the withdrawal of Essure from the United States after the FDA put pressure on it for post-market research after receiving 12,000 adverse reports.

If you had an Essure device inserted before March 2016, you participated in a follow-up appointment that confirmed the device was inserted in the proper location and had complications, contact us today to determine if you can join the more than 16,000 women who have already filed claims. Contact Tomes & Hanratty, P.C.